PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Phenotype | C0011570|depression |
| Sentences | 55 |
| PubMedID- 20804269 | Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis. |
| PubMedID- 26401158 | The results obtained from multiple logistic regression analysis showed that the disease course (or for relapsing–remitting ms = 2.36, % 95 ci = 1.14–5.53, p = 0.46), the expanded disability status scale (or for score of 5–8 = 4.88, % 95 ci = 2.51–11.06, p < 0.001) and employment status (or for housewife = 4.75, % 95 ci = 1.55–14.58, p = 0.006) were significant contributing factors to depression in patients with multiple sclerosis. |
| PubMedID- 26351621 | A brief description of the pathophysiology and effects of depression in patients with multiple sclerosis is also provided. |
| PubMedID- 23244804 | Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. |
| PubMedID- 23915778 | Perfectionism and physical disability predict depression in multiple sclerosis. |
| PubMedID- 23812284 | Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. |
| PubMedID- 19822449 | Fatigue and depression in children with multiple sclerosis and monophasic variants. |
| PubMedID- 24501169 | Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis. |
| PubMedID- 24653957 | Objective: the aim of this study was to investigate the course of alexithymia and its relation with anxiety and depression in patients with multiple sclerosis (ms), over a period of 5 years. |
| PubMedID- 26453680 | Background: depression is common in patients with multiple sclerosis (ms), although the brain mechanisms of this psychiatric condition in ms are poorly understood. |
| PubMedID- 20880067 | Stress and depression symptoms in patients with multiple sclerosis: the mediating role of the loss of social functioning. |
| PubMedID- 21948887 | Pathogenic mechanisms of depression in multiple sclerosis. |
| PubMedID- 23783007 | Objectives: duloxetine hydrochloride, a dual reuptake inhibitor of serotonin and norepinephrine, was evaluated for its therapeutic efficacy, safety, and tolerability in the treatment of depression in patients with multiple sclerosis (ms). |
| PubMedID- 22168507 | Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. |
| PubMedID- 25603363 | Conclusion our study suggests that coq10 supplementation (500 mg/day) can improve fatigue and depression in patients with multiple sclerosis. |
| PubMedID- 20812812 | Perceived social support and depression among veterans with multiple sclerosis. |
| PubMedID- 23379265 | Telephone-based physical activity counseling for major depression in people with multiple sclerosis. |
| PubMedID- 23097716 | A common challenge for correctly diagnosing depression in the context of multiple sclerosis is distinguishing whether a certain symptom emanates from a depressive disorder or can be attributed to the demyelinating disease. |
| PubMedID- 24926444 | [26] forty sessions of ai chi aquatic exercise (ae) program improves pain, spasms, disability, fatigue, depression, and autonomy in patient with multiple sclerosis. |
| PubMedID- 21585189 | depression in multiple sclerosis patients. |
| PubMedID- 26359900 | An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. |
| PubMedID- 24852924 | depression in multiple sclerosis: a long-term longitudinal study. |
| PubMedID- 24406031 | We systematically reviewed published controlled trials on the effectiveness of cognitive behavioural therapy (cbt) for the treatment of depression in people with multiple sclerosis. |
| PubMedID- 23754606 | Commentary on: predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study. |
| PubMedID- 20007425 | depression is common in patients with multiple sclerosis, but to date no studies have explored diffusion tensor imaging indices associated with mood change. |
| PubMedID- 25933976 | Zinc sulphate: a reasonable choice for depression management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. |
| PubMedID- 21621796 | Anxiety and depression in multiple sclerosis patients around diagnosis. |
| PubMedID- 23095427 | Evaluation of the 9-item patient health questionnaire (phq-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis. |
| PubMedID- 21328292 | Pharmacologic treatment of depression in multiple sclerosis. |
| PubMedID- 21995045 | In our experiments, we demonstrate the robustness of our method by applying it to map hippocampal atrophy of multiple sclerosis patients with depression on a data set of 109 subjects. |
| PubMedID- 26445703 | However, there is a paucity of data on diagnostic accuracy of self-report measures for depression in multiple sclerosis (ms). |
| PubMedID- 26254948 | Objective: to evaluate the efficacy of a telephone-delivered self-management intervention for fatigue, pain, and depression in adults with multiple sclerosis (ms). |
| PubMedID- 22860028 | A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the uk ms register. |
| PubMedID- 26223270 | depression in multiple sclerosis: the utility of common self-report instruments and development of a disease-specific measure. |
| PubMedID- 24559790 | Objective: the prevalence of depression in multiple sclerosis (ms) is known to be elevated, but nearly all available studies have estimated period prevalence. |
| PubMedID- 23713732 | The co-occurrence of pain and depression in adults with multiple sclerosis. |
| PubMedID- 20809354 | The purpose of the study was to evaluate the prevalence of insomnia in multiple sclerosis patients with comorbid depression, associations between psychological symptoms, multiple sclerosis symptoms and insomnia, and to test effects of a 16-week protocol-based psychotherapy intervention for depression on insomnia symptoms. |
| PubMedID- 20830648 | Assessment of depression in multiple sclerosis: development of a "trunk and branch" model. |
| PubMedID- 25444450 | depression in multiple sclerosis. |
| PubMedID- 25580882 | Disability identity predicts lower anxiety and depression in multiple sclerosis. |
| PubMedID- 20663242 | Both social support and stress predict depression in multiple sclerosis (ms) patients. |
| PubMedID- 24453767 | Attributional style and depression in multiple sclerosis: the learned helplessness model. |
| PubMedID- 22527232 | Quality of life and depression in multiple sclerosis patients: longitudinal results of the betaplus study. |
| PubMedID- 25061435 | Background: valid assessments are needed in order to identify anxiety and depression in people with multiple sclerosis (ms). |
| PubMedID- 25362584 | Effect of neurofeedback training on depression and fatigue in patients with multiple sclerosis. |
| PubMedID- 19941048 | This study is a secondary analysis from a randomized clinical trial examining telephone-administered psychotherapy treatments for depression among patients with multiple sclerosis (please see mohr et al. |
| PubMedID- 20204955 | We assessed the applicability of ccbt for the treatment of depression in people with multiple sclerosis (ms). |
| PubMedID- 20070277 | Predictors of depression in multiple sclerosis patients. |
| PubMedID- 26008945 | Selective serotonin-reuptake inhibitors (ssris), commonly administered for depression and anxiety in patients with multiple sclerosis, are associated with qt interval prolongation. |
| PubMedID- 26242758 | Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care hospital in oman. |
Page: 1 2